Decreased serum testosterone in men with acute ischemic stroke

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 6, 1996, Pages 749-754

  Jeppesen, Lise Leth ^a,d   Jørgensen, Henrik Stig ^c   Nakayama, Hirofumi ^c   Raaschou, Hans Otto ^c   Olsen, Tom Skyhøj ^c   Winther, Kaj ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b KOLDING HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

risk factor; sex hormones; stroke; testosterone

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

EID: 0029980841     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.6.749     Document Type: Article

References (54)

1. Boysen G, Nyhoe J, Appleyard M, Sorensen PS, Boas J, Somnier F, Jensen G, Schnohr P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988;19:1345-1353.
2. Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids. 1990;55:330-352.
3. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-1131.
4. Barrett Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men: a prospective population-based study. Circulation. 1988;78:539-545.
5. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994;14:701-706.
6. Yarnell JW, Beswick AD, Sweetnam PM, Riad Fahmy D. Endogenous sex hormones and ischemic heart disease in men: the Caerphilly prospective study. Arterioscler Thromb. 1993;13:517-520.
7. Ajayi AAL, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A: receptor density and aggregation responses. Circulation. 1995;91:2742-2747.
8. Johnson M, Ramey E, Ramwell PW. Androgen-mediated sensitivity in platelet aggregation. Am J Physiol. 1977;232:H381-H385.
9. Uzunova A, Ramey E, Ramwell PW. Effect of testosterone, sex and age on experimentally induced arterial thrombosis. Nature. 1976;261:712-713.
10. Yang XC, Jing TY, Rcsnick LM, Phillips GB. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. Arterioscler Thromb. 1993;13:467-471.
11. Caron P, Bennet A, Camare R, Louvet JP, Boneu B, Sie P. Plasminogen activator inhibitor in plasma is related to testosterone in men. Metabolism. 1989;38:1010-1015.
12. Marques-Vidal P, Sie P, Cambou JP, Chap H, Perret B. Relationships of plasminogen activator inhibitor activity and lipoprotein(a) with insulin, testosterone, 17-beta-estradiol, and testosterone binding globulin in myocardial infarction patients and healthy controls. J Clin Endocrinol Metab. 1995;80:1794-1798.
13. Bonithon Kopp C, Scarabin PY, Bara L, Castanier M, Jacqueson A, Roger M. Relationship between sex hormones and haemostatic factors in healthy middle-aged men. Atherosclerosis. 1988;71:71-76.
14. Heller RF, Meade TW, Haines AP, Stirling Y, Miller NE, Lewis B. Inter-relationships between factor VII, serum testosterone and plasma lipoproteins. Thromb Res. 1982;28:423-425.
15. Henriksson P, Edhag O. Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. Br Med J Clin Res Ed. 1986;293:413-415.
16. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group: the Coronary Drug Project Research Group. JAMA. 1973;226:652-657.
17. Jorgensen HS, Nakayama H, Raaschou HO, Gam J, Olsen TS. Silent infarction in acute stroke patients: prevalence, localization, risk factors, and clinical significance: the Copenhagen Stroke Study. Stroke. 1994;25:97-104.
18. WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke, 1989: recommendations on stroke prevention, diagnosis, and therapy. Stroke. 1989;20:1407-1431.
19. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Stroke. 1985;16:885-890.
20. Lindenstrom E, Boysen G, Christiansen LW, Rogvi Hansen B, Nielsen PW. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis. 1991;1:103-107.
21. Abraham GE, Manilos FS, Garza R. Radioimmunoassay of steroids. In: Abraham GE, ed. Handbook of Radioimmunoassay. New York, NY: Marcel Dekker; 1977:591-656.
22. Statistical Package for the Social Sciences, version 6.1. Chicago, Ill: SPSS, Inc; 1995.
23. Wang C, Chan V, Tse TF, Yeung RT. Effect of acute myocardial infarction on pituitary-testicular function. Clin Endocrinol (Oxf). 1978;9:249-253.
24. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab. 1985;60:444-450.
25. Rudman D, Fleischer AS, Kutner MH, Raggio JF. Suprahypophyseal hypogonadism and hypothyroidism during prolonged coma after head trauma. J Clin Endocrinol Metab. 1977;45:747-754.
26. Winther K, Knudsen JB, Gormsen J. Influence of stanozolol on euglobulin clot lysis. In: Davidson JF, Coccheri S, eds. Progress in Fibrinolysis. New York, NY: Churchill Livingstone; 1985:97-101.
27. Kluft C, Preston FE, Malia RG, Bertina RM, Wijngaards G, Greaves M, Verheijen JH, Dooijewaard G. Stanozolol-induced changes in fibrinolysis and coagulation in healthy adults. Thromb Haemost. 1984;51:157-164.
28. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord. 1992;16:991-997.
29. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092-1098.
30. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol. 1993;28:623-627.
31. Lindholm J, Winkel P, Brodthagen U, Gyntelberg F. Coronary risk factors and plasma sex hormones. Am J Med. 1982;73:648-651.
32. Barrett Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol. 1990;132:895-901.
33. Small M, MacRury S, Beastall GH, MacCuish AC. Oestradiol levels in diabetic men with and without a previous myocardial infarction. Q J Med. 1987;64:617-623.
34. Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab. 1994;79:1310-1316.
35. Haffner SM, Mykkanen L, Valdez RA, Katz MS. Relationship of sex hormones to lipids and lipoproteins in non-diabetic men. J Clin Endocrinol Metab. 1993;77:1610-1615.
36. Sewdarsen M, Jialal I, Vythilingum S, Desai R. Sex hormone levels in young Indian patients with myocardial infarction. Arteriosclerosis. 1986;6:418-421.
37. Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, O'Keefe T, MacDonald GJ. Sex hormones and coronary artery disease. Am J Med. 1987;83:853-859.
38. Lichtenstein MJ, Yarnell JW, Elwood PC, Beswick AD, Sweetnam PM, Marks V, Teale D, Riad Fahmy D. Sex hormones, insulin, lipids, and prevalent ischemic heart disease. Am J Epidemiol. 1987;126:647-657.
39. Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism. 1993;42:116-120.
40. Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery. 1983;12:1-23.
41. Dai WS, Kuller LH, LaPorte RE, Gutai JP, Falvo Gerard L, Caggiula A. The epidemiology of plasma testosterone levels in middle-aged men. Am J Epidemiol. 1981;114:804-816.
42. Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol Metab. 1987;65:1118-1126.
43. Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983;56:1278-1281.
44. Nankin HR, Calkins JH. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab. 1986;63:1418-1420.
45. Harman SM, Tsitouras PD. Reproductive hormones in aging men, I: measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab. 1980;51:35-40.
46. Appleyard M. The Copenhagen City Heart Study: Østerbroundersgelsen. Scand J Soc Med. 1987;suppl 41:92-93.
47. Spratt DI, O'Dea LS, Schoenfeld D, Butler J, Rao PN, Crowley WF Jr. Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol. 1988;254:E658-E666.
48. Lacerda L, Kowarski A, Johanson AJ, Athanasiou R, Migeon CJ. Integrated concentration and circadian variation of plasma testosterone in normal men. J Clin Endocrinol Metab. 1973;37:366-371.
49. de la Torre B, Sjoberg B, Hedman M, Bartfai G, Diczfalusy E. A study of the short-time variation and interrelationship of plasma hormone levels reflecting pituitary, adrenocortical and testicular function in fertile men. Int J Androl. 1981;4:532-545.
50. Plymate SR, Tenover JS, Bremner WJ. Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men. J Androl. 1989;10:366-371.
51. Deslypere JP, Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab. 1984;59:955-962.
52. Reinberg A, Lagoguey M, Chauffournier JM, Ccsselin F. Circannual and circadian rhythms in plasma testosterone in five healthy young Parisian males, Acta Endocrinol Copenh. 1975;80:732-743.
53. Smals AG, Kloppenborg PW, Benraad TJ. Circannual cycle in plasma testosterone levels in man. J Clin Endocrinol Metab. 1976;42:979-982.
54. Winters SJ, Sherins RJ, Troen P. The gonadotropic suppressive activity of androgens is increased in elderly men. Metabolism. 1984;33:1052-1059.